UNSPSC 51172322: Dicobalt edetate

This classification denotes a protective agent with the molecular formula C10H12N2O8.2Co, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UKC6GH80QR, chemically known as cobaltate(2-), ((n,n-1,2-ethanediylbis(n-(carboxymethyl)glycinato))(4-)-n,n,o,o,o(sup n), o(sup n))-, cobalt(2+) (1:1), (oc-6-21) but generally known as dicobalt edetate, which bears US NIH Compound Identifier 71942. European Medicines Agency schedules Dicobalt edetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13569MIG.

UNSPSC 51172322 Dicobalt edetate is a Commodity code identifying a chelating agent used in medical and toxicology contexts, but state and local procurement activity under this code does not align with the nominal scope. The single recent opportunity identified — Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services — addresses laboratory testing and staffing for criminal justice supervision, not the procurement of dicobalt edetate reagent itself. The solicitation calls for immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing methodologies, and Interactive Voice Response system operation across two Texas collection sites, with an estimated contract value of $600,000 over two years plus three optional one-year renewals. Vendors must hold SAMHSA, Texas DPS, or CAP laboratory certification and will be evaluated on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional demonstrations and interviews (up to 30 points). Pricing is submitted on a per-test basis across three service models: screening only, confirmation after screening, and screening with automatic confirmation of positives.

The code shows minimal relevant recent activity in state and local procurement. Collin County's July 23, 2026 RFP response date represents the only identifiable opportunity, and it addresses drug-testing laboratory services and specimen collection staffing rather than chemical reagent procurement. The mismatch between the code's nominal scope (dicobalt edetate as a discrete chemical product) and the actual work being solicited suggests either miscoding by the issuing body or that this Commodity code does not reflect active state and local buying patterns for the chemical itself. Practitioners should monitor whether future dicobalt edetate procurement emerges under this code or whether laboratory-services codes better capture the actual demand.